Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

TransMedics Group, Inc. (TMDX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
31.29-0.86 (-2.67%)
At close: 04:00PM EDT
31.25 -0.04 (-0.13%)
After hours: 07:58PM EDT
Advertisement

TransMedics Group, Inc.

200 Minuteman Road
Suite 302
Andover, MA 01810
United States
978 552 0900
https://www.transmedics.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees148

Key Executives

NameTitlePayExercisedYear Born
Dr. Waleed H. Hassanein M.D.Founder, Pres, MD, CEO & Director992.42k7.62M1968
Mr. Stephen GordonCFO. Treasurer & Sec.529.32k1.79M1968
Dr. Tamer I. Khayal M.D.Chief Commercial Officer551.37k1.67M1969
Ms. Miriam C. Provost Ph.D.VP of Global Regulatory Affairs439.19k158.85kN/A
Ms. Laura DammeVP of Clinical Affairs337.31kN/AN/A
Mr. John F. CareyVP of OperationsN/AN/A1965
Mr. Ike OkonkwoVP of Fin. & AccountingN/AN/A1971
Mr. Mark AndersonSr. Director of Technology Devel.N/AN/AN/A
Ms. Susan GoodmanVP of HRN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Corporate Governance

TransMedics Group, Inc.’s ISS Governance QualityScore as of June 1, 2022 is 5. The pillar scores are Audit: 5; Board: 2; Shareholder Rights: 3; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement